Farzin Khosrow-Khavar, PhD

Assistant Professor of Epidemiology,
Department of Biostatistics and Epidemiology, Rutgers School of Public Health

Core Member, Center for Pharmacoepidemiology and Treatment Science,
Rutgers Institute for Health, Health Care Policy and Aging Research

Farzin Khosrow-Khavar is an Assistant Professor of Epidemiology with the Department of Biostatistics and Epidemiology at Rutgers School of Public Health, a core member of PETS, and an affiliate member of Rutgers Cancer Institute. Dr. Khosrow-Khavar is an epidemiologist with a focus on integrating advanced study designs and methods with large electronic health records to generate robust evidence that informs the equitable, effective, and safe use of cancer treatments in clinical practice. He is currently leading observational studies, funded by a career development award from the American Heart Association, to advance the evidence base for the cardiovascular management and outcomes of patients diagnosed with prostate cancer. Dr. Khosrow-Khavar received his Ph.D. in Epidemiology from McGill University and completed his postdoctoral training at Brigham and Women’s Hospital. He has conducted numerous pharmacoepidemiologic studies examining the safety of drugs used in management of hormone-sensitive malignancies. His work has been published in Circulation, Journal of Clinical Oncology, Annals of Oncology, Annals of the Rheumatic Diseases, and American Journal of Epidemiology.

Select Publications:

1. Khosrow-Khavar F, Azoulay L, Montastruc F, Montastruc JL, Renoux C. Aromatase Inhibitors and Risk of Parkinsonism in Women Diagnosed with Breast Cancer: Population Based Cohort Study. Cancer, 2022 Apr 1. doi: 10.1002/cncr.34208.
2. Khosrow-Khavar F, Kim, SC, Lee H, Lee S, Desai RJ. Tofacitinib and Risk of Cardiovascular Outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) Study. Ann Rheum Dis. 2022. doi: 10.1136/annrheumdis-2021-221915.
3. Khosrow-Khavar F, Filion KB, Bouganim N, Suissa S, Azoulay L. Aromatase Inhibitors and Risk of Cardiovascular Disease in Women with Breast Cancer. Circulation,141(7): 549-559, 2020.
4. Khosrow-Khavar F, Filion KB, Bouganim N, Suissa S, Azoulay L. Cardiotoxic Effects of Sequential Aromatase Inhibitors Use in Women with Breast Cancer. American Journal of Epidemiology, 89(10): 1086-1095, 2020.
5. Khosrow-Khavar F, Yin H, Barkun A, Bouganim N, Azoulay L. Aromatase Inhibitors and the Risk of Colorectal Cancer in Post-Menopausal Women with Breast Cancer. Annals of Oncology, 29(3): 744-748, 2018.
6. Khosrow-Khavar F, Rej S, Yin H, Aprikian A, Azoulay L. Androgen Deprivation Therapy and Risk of Dementia in Patients with Prostate Cancer. Journal of Clinical Oncology, 35(2): 201-207, 2017.

Full publication list on Google Scholar: https://scholar.google.com/citations?user=CAe4RDcAAAAJ&hl=en&oi=ao

Active Grants:

Title: Strengthening the evidence base for the cardiovascular management of patients diagnosed with prostate cancer (24CDA1259477)
Source of Support: American Heart Association (AHA)
Project/Proposal Start and End Date: 04/2024-03/2027
Role: Principal Investigator